Investing
Investing Cash Flow
Roivant Sciences Investing Cash Flow increased by 67.0% to -$1.09B in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 112409.4%, from -$965.00K to -$1.09B.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
Detailed definition
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Peer comparison
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
Metric ID:
net_cash_from_investingHistorical Data
12 periods
| Q2 '21 | Q3 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.34M | $317.41M | -$7.46M | -$146.85M | -$3.51M | $105.00K | -$36.45M | $5.23B | $6.93M | -$965.00K | -$3.29B | -$1.09B |
| QoQ Change | — | >999% | -102.3% | <-999% | +97.6% | +103.0% | <-999% | >999% | -99.9% | -113.9% | <-999% | +67.0% |
| YoY Change | — | — | -218.9% | -146.3% | — | +101.4% | +75.2% | >999% | — | <-999% | <-999% | <-999% |
Range-$3.29B – $5.23B
CAGR+832.6%
Avg YoY Growth>999%
Median YoY Growth-182.6%
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's investing cash flow?
- Roivant Sciences (ROIV) reported investing cash flow of -$1.09B in Q2 2025.
- How has Roivant Sciences's investing cash flow changed year-over-year?
- Roivant Sciences's investing cash flow decreased by 112409.4% year-over-year, from -$965.00K to -$1.09B.
- What does investing cash flow mean?
- The net amount of cash spent on or received from investing activities.